Showing results (261-270 of 364) with videos related to
Sort By:
Pageof 37
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 2, 2019
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant CyclophosphamideShannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation CyclophosphamideAmy E DeZern, Hany Elmariah, Marianna Zahurak, et al.European Urology Focus|July 30, 2017
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient CohortJennifer Cullen, Denise Young, Yongmei Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group StudyRoisin M Connolly, Eric Laille, Ulka Vaishampayan, et al.Prostate Cancer and Prostatic Diseases|December 14, 2018
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient populationGyorgy Petrovics, Douglas K Price, Hong Lou, et al.Haematologica|May 30, 2015
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemiaJoshua F Zeidner, Matthew C Foster, Amanda L Blackford, et al.Journal of Translational Medicine|January 9, 2020
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancerMichael A Kiebish, Jennifer Cullen, Prachi Mishra, et al.Journal of the National Cancer Institute|December 19, 2018
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in OncologyBrian P Hobbs, Pedro C Barata, Yada Kanjanapan, et al.Cancers|May 21, 2020
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer ProgressionYuqian Gao, Yi-Ting Wang, Yongmei Chen, et al.Nature Medicine|January 5, 2023
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment responseShawn H R Lee, Wenjian Yang, Yoshihiro Gocho, et al.Pageof 37